John E. Markis

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +14

Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.

Raymond G. McKay, Marc A. Pfeffer, R C Pasternak et al. · Circulation · 1986 · 723 citations

Thrombosis, Heart Failure, Cardiovascular Disease +14

Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

Edwin G. Bovill, Michael L. Terrin, David C. Stump et al. · Annals of Internal Medicine · 1991 · 481 citations

RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM

SamuelZ. Goldhaber, John A. Heit, G.V.R.K. Sharma et al. · The Lancet · 1988 · 368 citations

Thrombosis, Translational Medicine, Pulmonary Embolism +4

Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial Infarction

John E. Markis, Michael Malagold, J. Anthony Parker et al. · New England Journal of Medicine · 1981 · 280 citations